People · Operator
Named in public records as an officer, director or promoter · active 2008–2025 · Biotechnology, Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Uptake Medical Corp | — | Biotechnology | Series C | $113.2M | $98.2M | 2008 |
| Hygieia Inc | — | Other Health Care | Series A | $20.7M | $26.6M | 2017 |
| Thermalin Diabetes, LLC | — | Biotechnology | Series A | $19.5M | $240.6M | 2010 |
| Thermalin Inc. | — | Biotechnology | Series B | $19.5M | $92.8M | 2017 |
| AltrixBio, Inc. | — | Pharmaceuticals | Series A | $7.8M | $4.1M | 2019 |
| Noxilizer Inc | — | Biotechnology | Seed | $6.4M | $34.4M | 2010 |
| Alertgy Inc. | — | Other Health Care | Pre-Seed | $950K | $3.4M | 2023 |
| Sernova Biotherapeutics Inc. | — | Biotechnology | Pre-Seed | $345K | $694K | 2025 |
John Brooks at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Brooks on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Berenson | 2 | 4 |
| Michael Weiss | 1 | 8 |
| Scott Huennekens | 1 | 7 |
| Eric Kim | 1 | 7 |
| JAMES PARSONS | 1 | 6 |
| Andrew Schiff | 1 | 5 |
| Carl Simpson | 1 | 4 |
| Stephen Schaefer | 1 | 4 |
| Michael Hoey | 1 | 4 |
| NANCY BRIEFS | 1 | 4 |
| Karen Drexler | 1 | 4 |
| Jonathan Rigby | 1 | 4 |
| David Walton | 1 | 3 |
| J.C. MacRae | 1 | 3 |
| Jeffrey Karp | 1 | 3 |
| Raymond Rackley | 1 | 3 |
| Katherine Bowdish | 1 | 3 |
| Charles Bisgaier | 1 | 3 |
| DAVID BURKE | 1 | 3 |
| John Picerne | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.